First Trust Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.7M | Sell |
290,970
-38,182
| -12% | -$7.49M | 0.04% | 536 |
|
|
2026
Q1 | $64.5M | Sell |
329,152
-22,557
| -6% | -$4.38M | 0.05% | 481 |
|
|
2025
Q4 | $61M | Sell |
351,709
-19,839
| -5% | -$3.61M | 0.04% | 485 |
|
|
2025
Q3 | $70.8M | Buy |
371,548
+19,955
| +6% | +$3.54M | 0.05% | 432 |
|
|
2025
Q2 | $63.2M | Sell |
351,593
-114,868
| -25% | -$20M | 0.05% | 458 |
|
|
2025
Q1 | $78.9M | Sell |
466,461
-26,459
| -5% | -$4.35M | 0.07% | 349 |
|
|
2024
Q4 | $74.4M | Sell |
492,920
-56,708
| -10% | -$8.82M | 0.07% | 380 |
|
|
2024
Q3 | $85.3M | Sell |
549,628
-38,102
| -6% | -$5.69M | 0.08% | 279 |
|
|
2024
Q2 | $80.4M | Sell |
587,730
-161,107
| -22% | -$22.1M | 0.08% | 258 |
|
|
2024
Q1 | $99.7M | Buy |
748,837
+9,150
| +1% | +$1.19M | 0.1% | 228 |
|
|
2023
Q4 | $102M | Sell |
739,687
-41,422
| -5% | -$5.45M | 0.11% | 221 |
|
|
2023
Q3 | $95.2M | Buy |
781,109
+2,455
| +0.3% | +$327K | 0.11% | 218 |
|
|
2023
Q2 | $109M | Sell |
778,654
-12,358
| -2% | -$1.7M | 0.12% | 201 |
|
|
2023
Q1 | $112M | Buy |
791,012
+22,724
| +3% | +$3.25M | 0.13% | 195 |
|
|
2022
Q4 | $120M | Sell |
768,288
-125,197
| -14% | -$18M | 0.14% | 193 |
|
|
2022
Q3 | $110M | Buy |
893,485
+70,767
| +9% | +$9.32M | 0.14% | 183 |
|
|
2022
Q2 | $109M | Buy |
822,718
+102,446
| +14% | +$14M | 0.14% | 199 |
|
|
2022
Q1 | $98.6M | Sell |
720,272
-53,670
| -7% | -$7.48M | 0.1% | 255 |
|
|
2021
Q4 | $134M | Sell |
773,942
-1,292,230
| -63% | -$197M | 0.13% | 194 |
|
|
2021
Q3 | $300M | Buy |
2,066,172
+36,731
| +2% | +$5.37M | 0.32% | 51 |
|
|
2021
Q2 | $268M | Buy |
2,029,441
+99,094
| +5% | +$13M | 0.29% | 69 |
|
|
2021
Q1 | $248M | Buy |
1,930,347
+1,331,434
| +222% | +$164M | 0.3% | 62 |
|
|
2020
Q4 | $71.4M | Buy |
598,913
+26,243
| +5% | +$3.2M | 0.09% | 281 |
|
|
2020
Q3 | $65.6M | Sell |
572,670
-59,743
| -9% | -$7.06M | 0.11% | 249 |
|
|
2020
Q2 | $72.1M | Sell |
632,413
-93,413
| -13% | -$9.91M | 0.12% | 201 |
|
|
2020
Q1 | $58.3M | Buy |
725,826
+13,346
| +2% | +$1.38M | 0.13% | 216 |
|
|
2019
Q4 | $76.1M | Buy |
712,480
+51,383
| +8% | +$5.36M | 0.13% | 199 |
|
|
2019
Q3 | $70.8M | Sell |
661,097
-29,620
| -4% | -$3.04M | 0.13% | 196 |
|
|
2019
Q2 | $70.3M | Sell |
690,717
-145,857
| -17% | -$14M | 0.13% | 201 |
|
|
2019
Q1 | $75.2M | Buy |
836,574
+189,194
| +29% | +$16.4M | 0.15% | 169 |
|
|
2018
Q4 | $53.9M | Buy |
647,380
+471,075
| +267% | +$44.2M | 0.13% | 191 |
|
|
2018
Q3 | $19M | Sell |
176,305
-72,511
| -29% | -$7.95M | 0.04% | 636 |
|
|
2018
Q2 | $27.4M | Sell |
248,816
-129,061
| -34% | -$13.4M | 0.06% | 425 |
|
|
2018
Q1 | $37.9M | Buy |
377,877
+160,835
| +74% | +$16.5M | 0.09% | 276 |
|
|
2017
Q4 | $21.4M | Buy |
217,042
+84,577
| +64% | +$8.02M | 0.05% | 529 |
|
|
2017
Q3 | $12.4M | Sell |
132,465
-107,504
| -45% | -$11.4M | 0.03% | 684 |
|
|
2017
Q2 | $26.7M | Sell |
239,969
-45,732
| -16% | -$4.84M | 0.07% | 358 |
|
|
2017
Q1 | $28.1M | Sell |
285,701
-77,112
| -21% | -$7.35M | 0.08% | 322 |
|
|
2016
Q4 | $33.3M | Sell |
362,813
-38,632
| -10% | -$3.33M | 0.1% | 234 |
|
|
2016
Q3 | $34M | Sell |
401,445
-120,446
| -23% | -$10.1M | 0.1% | 228 |
|
|
2016
Q2 | $42.5M | Sell |
521,891
-114,146
| -18% | -$8.69M | 0.13% | 154 |
|
|
2016
Q1 | $45.4M | Sell |
636,037
-185,541
| -23% | -$12.4M | 0.15% | 147 |
|
|
2015
Q4 | $58.4M | Buy |
821,578
+396,942
| +93% | +$26.7M | 0.15% | 141 |
|
|
2015
Q3 | $26.1M | Sell |
424,636
-261,582
| -38% | -$18.3M | 0.08% | 292 |
|
|
2015
Q2 | $49.8M | Sell |
686,218
-108,107
| -14% | -$7.98M | 0.13% | 159 |
|
|
2015
Q1 | $61M | Sell |
794,325
-490,062
| -38% | -$35.1M | 0.18% | 114 |
|
|
2014
Q4 | $86.1M | Buy |
1,284,387
+22,238
| +2% | +$1.4M | 0.29% | 62 |
|
|
2014
Q3 | $76.6M | Buy |
1,262,149
+148,491
| +13% | +$9.15M | 0.3% | 51 |
|
|
2014
Q2 | $65.4M | Buy |
1,113,658
+41,687
| +4% | +$2.44M | 0.27% | 51 |
|
|
2014
Q1 | $62.1M | Buy |
1,071,971
+640,837
| +149% | +$34.3M | 0.27% | 47 |
|
|
2013
Q4 | $23.1M | Buy |
431,134
+253,074
| +142% | +$15M | 0.11% | 215 |
|
|
2013
Q3 | $11M | Sell |
178,060
-17,493
| -9% | -$1.05M | 0.06% | 496 |
|
|
2013
Q2 | $11.9M | Buy |
+195,553
| New | +$11.6M | 0.08% | 372 |
|
Other funds holding DGX
EIG
First Trust Advisors's DGX Position: Q2 2026 in Review
First Trust Advisors reduced its Quest Diagnostics (DGX) stake by 12% in Q2 2026, selling an estimated $7.49M and leaving 290,970 shares worth $61.7M. The position accounts for 0.04% of the portfolio, ranked #536.
First Trust Advisors first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $300M in Q3 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- First Trust Advisors held 290,970 shares of Quest Diagnostics worth $61.7M as of Q2 2026.
- First Trust Advisors sold 38,182 Quest Diagnostics shares in Q2 2026, an estimated $7.49M.
- Quest Diagnostics made up 0.04% of First Trust Advisors's portfolio in Q2 2026, its #536 holding.
- First Trust Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
- First Trust Advisors's Quest Diagnostics position peaked at $300M in Q3 2021.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.